<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.drugwiki.net/wen/index.php?action=history&amp;feed=atom&amp;title=Talk%3ADextrorphan</id>
	<title>Talk:Dextrorphan - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.drugwiki.net/wen/index.php?action=history&amp;feed=atom&amp;title=Talk%3ADextrorphan"/>
	<link rel="alternate" type="text/html" href="https://www.drugwiki.net/wen/index.php?title=Talk:Dextrorphan&amp;action=history"/>
	<updated>2026-11-07T08:07:16Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://www.drugwiki.net/wen/index.php?title=Talk:Dextrorphan&amp;diff=9003&amp;oldid=prev</id>
		<title>Sysop: 1 revision imported</title>
		<link rel="alternate" type="text/html" href="https://www.drugwiki.net/wen/index.php?title=Talk:Dextrorphan&amp;diff=9003&amp;oldid=prev"/>
		<updated>2025-11-01T14:17:53Z</updated>

		<summary type="html">&lt;p&gt;1 revision imported&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:17, 1 November 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;en&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key drugwiki_drugwikien:diff:1.41:old-9002:rev-9003 --&gt;
&lt;/table&gt;</summary>
		<author><name>Sysop</name></author>
	</entry>
	<entry>
		<id>https://www.drugwiki.net/wen/index.php?title=Talk:Dextrorphan&amp;diff=9002&amp;oldid=prev</id>
		<title>en&gt;LockPicker: standardizing</title>
		<link rel="alternate" type="text/html" href="https://www.drugwiki.net/wen/index.php?title=Talk:Dextrorphan&amp;diff=9002&amp;oldid=prev"/>
		<updated>2020-11-13T22:32:36Z</updated>

		<summary type="html">&lt;p&gt;standardizing&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{decree|type=notice|message=This article is in the &amp;#039;Talk&amp;#039; namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you&amp;#039;d like to use this area to discuss this draft, please do so in the &amp;#039;Discussion&amp;#039; section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}}&lt;br /&gt;
{{headerpanel|{{approval}}}}&lt;br /&gt;
{{SummarySheet}}&lt;br /&gt;
{{SubstanceBox/DXO}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Dextrorphan&amp;#039;&amp;#039;&amp;#039; (also known as &amp;#039;&amp;#039;&amp;#039;DXO&amp;#039;&amp;#039;&amp;#039;) is a [[dissociative]] drug of the [[morphinan]] class. It&amp;#039;s the main active metabolite of [[dextromethorphan]] (&amp;#039;&amp;#039;&amp;#039;DXM&amp;#039;&amp;#039;&amp;#039;). It appears as a colorless powder.&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;quot;Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student.&amp;quot; Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
Dextrorphan is a dextrorotatory molecule of the morphinan class. It contains a phenanthrene core structure with one aromatic ring (benzene) bound to two saturated rings (cyclohexane). [[Dextromethorphan]] is metabolized in the body by o-demethylation through the CYP2D6 enzyme to form Dextrorphan.&amp;lt;ref&amp;gt;Cytochrome P450-dependent metabolism of dextromethorphan: fetal and adult studies. | https://www.ncbi.nlm.nih.gov/pubmed/1306804&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
The pharmacology of dextrorphan is similar to that of dextromethorphan (DXM). However, dextrorphan is much more potent as an [[NMDA receptor antagonist]] as well as essentially inactive as a [[serotonin]] [[reuptake inhibitor]].&amp;lt;ref&amp;gt;Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism: A Pilot Study | http://journals.lww.com/psychopharmacology/pages/articleviewer.aspx?year=1998&amp;amp;issue=08000&amp;amp;article=00014&amp;amp;type=abstract&amp;lt;/ref&amp;gt; DXO is an active chemical and contributes to the [[DXM#Subjective effects|subjective effects]] experienced when active doses of DXM are consumed.&amp;lt;ref&amp;gt;Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders - 3. Pharmacodynamics (January 2016) | https://www.researchgate.net/publication/292212463_Dextromethorphan_An_update_on_its_utility_for_neurological_and_neuropsychiatric_disorders&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Binding affinities (K&amp;lt;sub&amp;gt;i&amp;lt;/sub&amp;gt;)===&lt;br /&gt;
* NMDA antagonist - 486 nM&lt;br /&gt;
* Sigma-1 agonist - 351 nM&lt;br /&gt;
* Serotonin transporter (SERT) - 484 nM&lt;br /&gt;
* Mu opioid agonist - 420 nM&lt;br /&gt;
&lt;br /&gt;
==Subjective effects==&lt;br /&gt;
{{Preamble/SubjectiveEffects}}&lt;br /&gt;
&lt;br /&gt;
One user reported excessive itchiness accompanied by a &amp;quot;peaceful yet emotionless state&amp;quot; after 340mg of the substance was consumed.&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;quot;Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student.&amp;quot; Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml&amp;lt;/ref&amp;gt;&lt;br /&gt;
{{effects/base&lt;br /&gt;
|{{effects/physical|&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Appetite suppression]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Changes in felt bodily form]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Gustatory hallucinations]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Itchiness]]&amp;#039;&amp;#039;&amp;#039; - This effect has become subsequently known as &amp;quot;robo-itch&amp;quot; and though relatively common there are many users who never experience this particular effect while some individuals can experience it quite intensely.  &lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Muscle spasms]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Motor control loss|Motor control loss]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Pain relief]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Perception of decreased weight]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Physical autonomy]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Spatial disorientation]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Tactile disconnection]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Tactile suppression]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
}}&lt;br /&gt;
|{{effects/cognitive|&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Amnesia]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Conceptual thinking]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Consciousness disconnection]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Creativity enhancement]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Déjà vu]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Depersonalization]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Derealization]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Disinhibition]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Existential self-realization]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Immersion enhancement]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Increased music appreciation]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Information processing suppression]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Memory suppression]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Novelty enhancement]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Personal bias suppression]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Thought deceleration]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Time distortion]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Unity and interconnectedness]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
}}&lt;br /&gt;
}}&lt;br /&gt;
===Experience reports===&lt;br /&gt;
There are currently {{#ask:[[Category:DXO]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]].&lt;br /&gt;
{{#ask: [[Category:DXO]][[Category:Experience]]|format=ul|Columns=1}}&lt;br /&gt;
Additional experience reports can be found here:&lt;br /&gt;
*[https://www.erowid.org/experiences/subs/exp_DXO.shtml Erowid Experience Vaults: DXO]&lt;br /&gt;
&lt;br /&gt;
==Toxicity and harm potential==&lt;br /&gt;
{{toxicity}}&lt;br /&gt;
It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance.&lt;br /&gt;
===Lethal dosage===&lt;br /&gt;
===Tolerance and addiction potential===&lt;br /&gt;
===Dangerous interactions===&lt;br /&gt;
{{DangerousInteractions}}&lt;br /&gt;
{{DangerousInteractions/Intro}}&lt;br /&gt;
{{DangerousInteractions/Dissociatives}}&lt;br /&gt;
&lt;br /&gt;
==Legal issues==&lt;br /&gt;
{{legalStub}}&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Germany&amp;#039;&amp;#039;&amp;#039;: Dextrorphan is uncontrolled.{{citation needed|date=November 2020}}&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Poland&amp;#039;&amp;#039;&amp;#039;: Dextrorphan is unscheduled.&amp;lt;ref&amp;gt;List of scheduled substances in Poland. | http://www2.mz.gov.pl/wwwfiles/ma_struktura/docs/zal2_uopnarkomanii_29072005.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;United States&amp;#039;&amp;#039;&amp;#039;: Dextrorphan is unscheduled since October 1, 1976.&amp;lt;ref&amp;gt;DEA: &amp;quot;Lists of: Scheduling Actions Controlled Substances Regulated Chemicals&amp;quot;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Responsible use]]&lt;br /&gt;
*[[Dextromethorphan]]&lt;br /&gt;
*[[Dissociative]]&lt;br /&gt;
*[[NMDA receptor antagonist]]&lt;br /&gt;
*[[Morphinan]]&lt;br /&gt;
*[[MXE]]&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*[[wikipedia:Dextrorphan|Dextrorphan (Wikipedia)]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Psychoactive substance]]&lt;br /&gt;
[[Category:Morphinan]]&lt;br /&gt;
[[Category:Dissociative]]&lt;br /&gt;
[[Category:Approval]]&lt;br /&gt;
[[Category:Proofread]]&lt;/div&gt;</summary>
		<author><name>en&gt;LockPicker</name></author>
	</entry>
</feed>